Increased CAR T Regulatory Cells Mediate Relapse to CD19-CAR T Therapy

Article navigation

Research Watch| November 02 2022

Online ISSN: 2159-8290

Print ISSN: 2159-8274

2022

American Association for Cancer Research

Cancer Discov (2022) 12 (11): OF8.

Abstract

A higher number of CAR T regulatory cells is associated with disease progression after CD19-CAR therapy.

2022

American Association for Cancer Research

You do not currently have access to this content.

Don't already have an account? Register

You could not be signed in. Please check your email address / username and password and try again.